Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02164565

The Use of Tranexamic Acid (TXA) Intravenously, to Reduce Blood Loss in Proximal Femur Surgery

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The use of Tranexamic Acid (TXA) intravenously, to Reduce Blood Loss in proximal femur surgery.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic Acid (TXA) treatmentTranexamic Acid (TXA) treatment
DRUGcontrol grup: without Tranexamic Acid (TXA) treatment.control grup: without Tranexamic Acid (TXA) treatment.

Timeline

Start date
2014-06-01
Primary completion
2015-01-01
Completion
2015-03-01
First posted
2014-06-16
Last updated
2017-08-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02164565. Inclusion in this directory is not an endorsement.